Scientific paper - Original scientific paper
miRNA in prostate cancer: challenges toward translation
Epigenomics, 12 (2020), 6; 543-558. https://doi.org/10.2217/epi-2019-0275


Cite this document

Abramović, I., Ulamec, M., Ana, K. B., Bulić Jakuš, F., Ježek, D. & Sinčić, N. (2020). miRNA in prostate cancer: challenges toward translation. Epigenomics, 12. (6), 543-558. doi: 10.2217/epi-2019-0275

Abramović, Irena, et al. "miRNA in prostate cancer: challenges toward translation." Epigenomics, vol. 12, no. 6, 2020, pp. 543-558. https://doi.org/10.2217/epi-2019-0275

Abramović, Irena, Monika Ulamec, Katušić Bojanac Ana, Floriana Bulić Jakuš, Davor Ježek and Nino Sinčić. "miRNA in prostate cancer: challenges toward translation." Epigenomics 12, no. 6 (2020): 543-558. https://doi.org/10.2217/epi-2019-0275

Abramović, I., et al. (2020) 'miRNA in prostate cancer: challenges toward translation', Epigenomics, 12(6), pp. 543-558. doi: 10.2217/epi-2019-0275

Abramović I, Ulamec M, Ana KB, Bulić Jakuš F, Ježek D, Sinčić N. miRNA in prostate cancer: challenges toward translation. Epigenomics [Internet]. 2020 March [cited 2022 May 21];12(6):543-558. doi: 10.2217/epi-2019-0275

I. Abramović, M. Ulamec, K. B. Ana, F. Bulić Jakuš, D. Ježek and N. Sinčić, "miRNA in prostate cancer: challenges toward translation", Epigenomics, vol. 12, no. 6, pp. 543-558, March 2020. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:146208. [Accessed: 21 May 2022]

Please login to the repository to save this object to your list.